Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Ann Indian Acad Neurol ; 25(2): 239-245, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35693656

RESUMEN

Objectives: Study was conducted with aim of comparing subtypes types of NMOSD based on serology. Methods: In this retrospective study, patients ≥18 years were included satisfying IPND 2015 criteria. Three groups were created based on seropositivity for AQP4 antibody, MOG antibody or double seronegative. Demographic, clinical and imaging were compared using regression analysis. Results: Forty-six patients, 28 (60.9%) AQP4+, 11 (23.9%) MOG + and remaining 7 (15.2%) double seronegative were included. Thirty-seven patients (80.4%) had presenting symptoms localized to optic nerve and/or cord [AQP4 + 22 (78.5%), MOG + 9 (81.8%) and double seronegative 6 (85.7%)]. Presentation with bilateral optic neuritis was more common in AQP4- patients. Twenty (86.8%) out of the 23 patients who had relapsing disease localized to optic nerve and/or spinal cord [AQP4 + 13/14 (92.8%), MOG + 3/5 (60%) and double seronegative 4/4 (100%)]. Relapses were more common in AQP4+ (77% vs 12% vs10%). In AQP4 negative group disability (EDSS 4.2 vs 3.3) and progression index was relatively less (1.6 vs 1.1). CSF pleocytosis (38.8% vs 17.9%) and raised proteins (66.6% vs 32.1%) were also more common. Optic nerve MRI (>50% optic nerve and chiasma involvement) was more commonly abnormal in AQP4 negative (52.9% vs 31.2%). Regression analysis revealed females to be significantly higher in AQP4 positive NMOSD (89.3%) when compared to MOG positive (36.4%) and double seronegative (42.9%). Conclusion: Gender was the only significant difference between the three groups. There was trend towards greater disability and more relapses in AQP4 + groups.

2.
J Stroke Cerebrovasc Dis ; 30(7): 105811, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-33915391

RESUMEN

OBJECTIVE: To determine factors at hospitalization of cerebral venous thrombosis (CVT) which determine outcome at one year. METHODS: This was an ambispective study with outcome at one year follow up. Patients angiographically proven as CVT were included in study and functional modified Rankin Scale (mRS) determined at one year. They were dichotomized into "good" outcome (mRS 0-1) and "poor" outcome (mRS 2-6). Variables at admission were compared on univariate and then by cox proportional hazard regression for significance. Complications during follow up period were also compared. RESULTS: One hundred and seventy five patients were included, data of 71 was collected prospectively. One hundred and seventeen (66.9%) had "good" outcome while 58 (33.1%) had "poor" outcome. Univariate analysis showed poor outcome associated with age < 30 years, female sex, focal deficit, GCS ≤ 12, ≥3 sinuses involved and intracerebral haemorrhage. On Cox proportional hazard regression only GCS ≤ 12 was significant. Around 96% had complete/ partial recanalization at 6 months. Over one year, the complications included dural AV fistula in 10 (5.7%), intracranial hypertension in 4 (2.3%), venous thromboembolism in 6 (3.4%) and arterial infarct in 4 (2.3%). Proportions with complications in each group were similar. At one year 41 patients (25.2%) were continued on anticoagulation and 97 (55.2%) on antiepileptic drugs. Proportion in each group were similar. CONCLUSION: In patients with CVT, GCS ≤ 12 at admission was a predictor of poor functional outcome (mRS 2-6) at one year. During this period, complications were few and similar in the both the groups.


Asunto(s)
Evaluación de la Discapacidad , Escala de Coma de Glasgow , Admisión del Paciente , Trombosis de los Senos Intracraneales/diagnóstico , Trombosis de la Vena/diagnóstico , Adulto , Anticoagulantes/uso terapéutico , Anticonvulsivantes/uso terapéutico , Femenino , Estado Funcional , Humanos , Masculino , Valor Predictivo de las Pruebas , Pronóstico , Estudios Prospectivos , Recuperación de la Función , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Trombosis de los Senos Intracraneales/fisiopatología , Trombosis de los Senos Intracraneales/terapia , Factores de Tiempo , Trombosis de la Vena/fisiopatología , Trombosis de la Vena/terapia
3.
Ind Psychiatry J ; 29(2): 317-322, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-34158719

RESUMEN

INTRODUCTION: Chronic Migraine is defined as headache occurring on 15 or more days/month for more than 3 months, which, on at least 8 days/month, has the features of migraine headache. This constitutes 10%-15% of all migraine patients in a neurology clinic. Literature on psychological comorbidities of chronic migraine in India is scant and it will improve overall patient care once discerned. AIM: To screen for psychiatric comorbidities in chronic migraine patients. SUBJECTS AND METHODS: A cross-sectional study was conducted to compare overall psychiatric morbidity of 100 patients of chronic migraine and control group of 100 healthy individuals. RESULTS: Chronic migraine cases had more psychological disturbance in comparison to healthy control (61% vs. 4%). Psychiatric morbidity was more in patients with higher migraine disability assessment score (MIDAS) Scores and frequent relapses. Significant anxiety and depression was seen in women, higher age group and higher MIDAS Values. CONCLUSIONS: The prevalence of psychological distress in Chronic migraine was significantly more, implying that they experience more psychological distress than the general population. Identifying these will result in better patient care in addition to standard drugs.

4.
J Neurosci Rural Pract ; 10(4): 588-591, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31831976

RESUMEN

Background The data on the epidemiology of epilepsy are limited for developing countries including India. We estimated the incidence of epilepsy in a cohort of service personnel from India followed for over two decades. Materials and Methods The data for this epidemiological study were derived from the electronic medical records (EMRs) of the male service personnel. The participants (age < 18 years) were enrolled into active service between 1990 and 2015 in good health. The data pertaining to the diagnosis of epilepsy were derived from the EMR using the prevalent International Classification of Diseases codes. We calculated the incidence rate as per person-years (py) using appropriate statistical methods. Results Our data included 51,217 participants (median age: 33 years, range: 17-54) with a mean follow-up of 12.5 years, giving a cumulative follow-up duration of 613,925 py. A total of 291 patients developed epilepsy during the study, giving an incidence rate of 0.47 per 1000 py (95% confidence interval: 0.42-0.53). Undifferentiated spondyloarthropathy, central nervous system disorders, and alcohol dependence syndrome were the common comorbid ailments in patients with epilepsy. Conclusion Our cohort had a comparable incidence rate of epilepsy with other studies from India and abroad.

5.
Indian J Med Sci ; 66(5-6): 144-7, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23806989

RESUMEN

Psychoneuroendocrinology deals with the overlap disorders pertaining to three different specialties. Awareness about the somatic manifestations of psychiatric diseases and vice versa is a must for all the clinicians. The knowledge of this interlinked specialty is essential because of the obscure presentation of certain disorders. Our first case was treated as depressive disorder, whereas the diagnosis was hypogonadism with empty sella. Our second patient was managed as schizophrenia and the evaluation revealed bilateral basal ganglia calcification and a diagnosis of Fahr's disease. We report these cases for their unusual presentation and to highlight the importance of this emerging specialty.


Asunto(s)
Enfermedades de los Ganglios Basales/diagnóstico , Calcinosis/diagnóstico , Trastorno Depresivo/complicaciones , Síndrome de Silla Turca Vacía/complicaciones , Esquizofrenia/complicaciones , Adulto , Antipsicóticos , Enfermedades de los Ganglios Basales/complicaciones , Enfermedades de los Ganglios Basales/tratamiento farmacológico , Calcinosis/complicaciones , Calcinosis/tratamiento farmacológico , Calcio/uso terapéutico , Trastorno Depresivo/terapia , Síndrome de Silla Turca Vacía/tratamiento farmacológico , Disfunción Eréctil/tratamiento farmacológico , Disfunción Eréctil/etiología , Femenino , Humanos , Hipogonadismo/tratamiento farmacológico , Hipogonadismo/etiología , Masculino , Risperidona/uso terapéutico , Esquizofrenia/tratamiento farmacológico , Testosterona/uso terapéutico , Vitamina D/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...